Package 68180-261-01

Brand: divalproex sodium

Generic: divalproex sodium
NDC Package

Package Facts

Identity

Package NDC 68180-261-01
Digits Only 6818026101
Product NDC 68180-261
Product ID 68180-261_1fc9a662-2c99-4c65-b31c-ebee40f357aa
Description

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-261-01)

Marketing

Marketing Status
Marketed Since 2020-09-18
Brand divalproex sodium
Generic divalproex sodium
Sample Package No

Linked Drug Pages (1)

Divalproex sodium ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "1fc9a662-2c99-4c65-b31c-ebee40f357aa", "openfda": {"upc": ["0368180260028"], "unii": ["644VL95AO6"], "rxcui": ["1099563", "1099569"], "spl_set_id": ["1f081c74-9f73-4ed9-9157-8d73d586a409"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-261-01)", "package_ndc": "68180-261-01", "marketing_start_date": "20200918"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-261-02)", "package_ndc": "68180-261-02", "marketing_start_date": "20200918"}], "brand_name": "Divalproex sodium", "product_id": "68180-261_1fc9a662-2c99-4c65-b31c-ebee40f357aa", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "68180-261", "generic_name": "Divalproex sodium", "labeler_name": "Lupin Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Divalproex sodium", "active_ingredients": [{"name": "DIVALPROEX SODIUM", "strength": "500 mg/1"}], "application_number": "ANDA209286", "marketing_category": "ANDA", "marketing_start_date": "20200918", "listing_expiration_date": "20261231"}